ArticleJournal of neurology2017

Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis.

Luca Prosperini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.